期刊
BJU INTERNATIONAL
卷 108, 期 4, 页码 513-517出版社
WILEY-BLACKWELL
DOI: 10.1111/j.1464-410X.2010.09974.x
关键词
prostate cancer; active surveillance; magnetic resonance imaging; low risk; biopsy scheme; radical prostatectomy
OBJECTIVE To investigate the role of magnetic resonance imaging (MRI) in selecting patients for active surveillance (AS). PATIENTS AND METHODS We identified prostate cancers patients who had undergone a 21-core biopsy scheme and fulfilled the criteria as follows: prostate-specific antigen (PSA) level <= 10 ng/mL, T1-T2a disease, a Gleason score <= 6, <3 positive cores and tumour length per core <3 mm. We included 96 patients who underwent a radical prostatectomy (RP) and a prostate MRI before surgery. The main end point of the study was the unfavourable disease features at RP, with or without the use of MRI as AS inclusion criterion. RESULTS Mean age and mean PSA were 62.4 years and 6.1 ng/mL, respectively. Prostate cancer was staged pT3 in 17.7% of cases. The rate of unfavourable disease (pT3-4 and/or Gleason score >= 4 + 3) was 24.0%. A T3 disease on MRI was noted in 28 men (29.2%). MRI was not a significant predictor of pT3 disease in RP specimens (P = 0.980), rate of unfavourable disease (P = 0.604), positive surgical margins (P = 0.750) or Gleason upgrading (P = 0.314). In a logistic regression model, no preoperative parameter was an independent predictor of unfavourable disease in the RP specimen. After a mean follow-up of 29 months, the recurrence-free survival (RFS) was statistically equivalent between men with T3 on MRI and those with T1-T2 disease (P = 0.853). CONCLUSION The results of the present study emphasize that, when the selection of patients for AS is based on an extended 21-core biopsy scheme, and uses the most stringent inclusion criteria, MRI does not improve the prediction of high-risk and/or non organ-confined disease in a RP specimen.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据